These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 32337944)

  • 1. Rotenone: from modelling to implication in Parkinson's disease.
    Radad K; Al-Shraim M; Al-Emam A; Wang F; Kranner B; Rausch WD; Moldzio R
    Folia Neuropathol; 2019; 57(4):317-326. PubMed ID: 32337944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The behavioural and neuropathological impact of intranigral AAV-α-synuclein is exacerbated by systemic infusion of the Parkinson's disease-associated pesticide, rotenone, in rats.
    Mulcahy P; O'Doherty A; Paucard A; O'Brien T; Kirik D; Dowd E
    Behav Brain Res; 2013 Apr; 243():6-15. PubMed ID: 23295396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An update on the rotenone models of Parkinson's disease: their ability to reproduce the features of clinical disease and model gene-environment interactions.
    Johnson ME; Bobrovskaya L
    Neurotoxicology; 2015 Jan; 46():101-16. PubMed ID: 25514659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of the literature of rotenone, 1,2,12,12a-tetrahydro-8,9-dimethoxy-2-(1-methylethenyl)-1-benzopyrano[3,5-b]furo[2,3-h][1]benzopyran-6(6h)-one.
    Haley TJ
    J Environ Pathol Toxicol; 1978; 1(3):315-37. PubMed ID: 363963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection against dopaminergic neurodegeneration in Parkinson's disease-model animals by a modulator of the oxidized form of DJ-1, a wild-type of familial Parkinson's disease-linked PARK7.
    Inden M; Kitamura Y; Takahashi K; Takata K; Ito N; Niwa R; Funayama R; Nishimura K; Taniguchi T; Honda T; Taira T; Ariga H
    J Pharmacol Sci; 2011; 117(3):189-203. PubMed ID: 22041943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paraquat- and rotenone-induced models of Parkinson's disease.
    Nisticò R; Mehdawy B; Piccirilli S; Mercuri N
    Int J Immunopathol Pharmacol; 2011; 24(2):313-22. PubMed ID: 21658306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotective effect of α-mangostin on mitochondrial dysfunction and α-synuclein aggregation in rotenone-induced model of Parkinson's disease in differentiated SH-SY5Y cells.
    Hao XM; Li LD; Duan CL; Li YJ
    J Asian Nat Prod Res; 2017 Aug; 19(8):833-845. PubMed ID: 28696167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction between subclinical doses of the Parkinson's disease associated gene, α-synuclein, and the pesticide, rotenone, precipitates motor dysfunction and nigrostriatal neurodegeneration in rats.
    Naughton C; O'Toole D; Kirik D; Dowd E
    Behav Brain Res; 2017 Jan; 316():160-168. PubMed ID: 27585560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective Effects of Thymol, a Dietary Monoterpene Against Dopaminergic Neurodegeneration in Rotenone-Induced Rat Model of Parkinson's Disease.
    Javed H; Azimullah S; Meeran MFN; Ansari SA; Ojha S
    Int J Mol Sci; 2019 Mar; 20(7):. PubMed ID: 30934738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transferrin1 modulates rotenone-induced Parkinson's disease through affecting iron homeostasis in Drosophila melanogaster.
    Xue J; Wang HL; Xiao G
    Biochem Biophys Res Commun; 2020 Oct; 531(3):305-311. PubMed ID: 32800558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progression of Parkinson's disease pathology is reproduced by intragastric administration of rotenone in mice.
    Pan-Montojo F; Anichtchik O; Dening Y; Knels L; Pursche S; Jung R; Jackson S; Gille G; Spillantini MG; Reichmann H; Funk RH
    PLoS One; 2010 Jan; 5(1):e8762. PubMed ID: 20098733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An in vitro model of Parkinson's disease: linking mitochondrial impairment to altered alpha-synuclein metabolism and oxidative damage.
    Sherer TB; Betarbet R; Stout AK; Lund S; Baptista M; Panov AV; Cookson MR; Greenamyre JT
    J Neurosci; 2002 Aug; 22(16):7006-15. PubMed ID: 12177198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of endoplasmic reticulum stress-activated IRE1α-TRAF2-caspase-12 apoptotic pathway is involved in the neuroprotective effects of telmisartan in the rotenone rat model of Parkinson's disease.
    Tong Q; Wu L; Jiang T; Ou Z; Zhang Y; Zhu D
    Eur J Pharmacol; 2016 Apr; 776():106-15. PubMed ID: 26879867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Geraniol Protects Against the Protein and Oxidative Stress Induced by Rotenone in an In Vitro Model of Parkinson's Disease.
    Rekha KR; Inmozhi Sivakamasundari R
    Neurochem Res; 2018 Oct; 43(10):1947-1962. PubMed ID: 30141137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rotenone, deguelin, their metabolites, and the rat model of Parkinson's disease.
    Caboni P; Sherer TB; Zhang N; Taylor G; Na HM; Greenamyre JT; Casida JE
    Chem Res Toxicol; 2004 Nov; 17(11):1540-8. PubMed ID: 15540952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The neuroprotective effects of hydro-alcoholic extract of olive (Olea europaea L.) leaf on rotenone-induced Parkinson's disease in rat.
    Sarbishegi M; Charkhat Gorgich EA; Khajavi O; Komeili G; Salimi S
    Metab Brain Dis; 2018 Feb; 33(1):79-88. PubMed ID: 29039078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of reactive oxygen species in the neurotoxicity of environmental agents implicated in Parkinson's disease.
    Drechsel DA; Patel M
    Free Radic Biol Med; 2008 Jun; 44(11):1873-86. PubMed ID: 18342017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential pattern of motor impairments in neurotoxic, environmental and inflammation-driven rat models of Parkinson's disease.
    Naughton C; Moriarty N; Feehan J; O'Toole D; Dowd E
    Behav Brain Res; 2016 Jan; 296():451-458. PubMed ID: 26393432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PPARβ/δ Agonist Provides Neuroprotection by Suppression of IRE1α-Caspase-12-Mediated Endoplasmic Reticulum Stress Pathway in the Rotenone Rat Model of Parkinson's Disease.
    Tong Q; Wu L; Gao Q; Ou Z; Zhu D; Zhang Y
    Mol Neurobiol; 2016 Aug; 53(6):3822-3831. PubMed ID: 26160761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sitagliptin and liraglutide reversed nigrostriatal degeneration of rodent brain in rotenone-induced Parkinson's disease.
    Badawi GA; Abd El Fattah MA; Zaki HF; El Sayed MI
    Inflammopharmacology; 2017 Jun; 25(3):369-382. PubMed ID: 28258522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.